We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Therapeutic preparation.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Therapeutic preparation - List of Manufacturers, Suppliers, Companies and Products

Therapeutic preparation Product List

1～2 item / All 2 items

Displayed results
[Clinic for Cancer Patients] Cancer Immunotherapy Shin Beck

[Clinic for Cancer Patients] Cancer Immunotherapy Shin Beck

It is a cancer cell immunotherapy that processes unnecessary cancer cells and immune cells, which become unnecessary with ascites treatment CART (ascites filtration, concentration, and reinfusion method), and returns them to the patient's body.

"Shin Beck" is a cancer immunotherapy that processes the patient's own cells collected through CART (ascites treatment) and then administers them back to the patient to activate the immune cells in the body. It is possible to administer the treatment to the patient within a short period (about one week) after receiving the CART waste bag. The activated immune cells (such as NK and killer T cells) will kill the tumor cells. [Features] - Activates the immune cells in the body - Immune cells (NK and killer T cells) kill tumor cells - Can be administered to the patient within a short period (about one week) *For more details, please refer to the PDF document or feel free to contact us.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for CAR-T Therapy in Hematologic Malignancies

[Research Material] The Global Market for CAR-T Therapy in Hematologic Malignancies

Global Market for CAR-T Therapy in Hematologic Malignancies: Allogeneic, Autologous, Hospitals, Cancer Research Centers, Others

This research report (Global CAR-T Therapy in Haematological Malignancy Market) investigates and analyzes the current status and outlook for the global market of CAR-T therapy in hematological malignancies over the next five years. It includes information on the overview of the CAR-T therapy market in global hematological malignancies, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the CAR-T therapy market by type focus on allogeneic and autologous therapies, while the segments by application target hospitals, cancer research centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of CAR-T therapy in hematological malignancies. It also includes the market share of major companies in the CAR-T therapy market for hematological malignancies, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.